| Ytd | 17.85% | |
| 1y | 17.85% |
| Open | 22.10 | Prev Close | 22.03 | Low | 21.74 | High | 22.17 | Mkt Cap | 6.13B |
| Vol | 2.88M | Avg Vol | 1.59M | EPS | -1.12 | P/E | N/A | Forward P/E | 34.09 |
| Beta | N/A | Short Ratio | 6.66 | Inst. Own | 13.54% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 11-16 | 50-d Avg | 19.50 | 200-d Avg | 16.03 | 1yr Est | 24.55 |
MiniMed (NASDAQ:MMED) announced that it has filed a Form S-4 Registration Statement today with the S
Medtronic shareholders can exchange their Medtronic ordinary shares for shares of MiniMed Provides
NORTHRIDGE, Calif., Sept. 14, 2026 /PRNewswire/ -- MiniMed (Nasdaq: MMED) announced that it has file
Morgan Stanley analyst Kallum Titchmarsh maintains Minimed Group (NASDAQ:MMED) with a Overweight
Citigroup analyst Joanne Wuensch maintains Minimed Group (NASDAQ:MMED) with a Buy and raises the
Evercore ISI Group analyst Daniel Markowitz maintains Minimed Group (NASDAQ:MMED) with a Outperfo
Wells Fargo analyst Larry Biegelsen maintains Minimed Group (NASDAQ:MMED) with a Overweight and r
U.S. stocks rose; Sirius XM jumped 5.5% after Deutsche Bank’s upgrade, while GitLab, Dell and other
MiniMed Group beat Q1 sales estimates with 16.6% growth to $843M; shares rose 7.1% as analysts raise
UBS analyst Patrick Wood maintains Minimed Group (NASDAQ:MMED) with a Buy and raises the price ta
Mizuho analyst Anthony Petrone maintains Minimed Group (NASDAQ:MMED) with a Outperform and raises
B of A Securities analyst Travis Steed maintains Minimed Group (NASDAQ:MMED) with a Buy and raise
BTIG analyst Marie Thibault maintains Minimed Group (NASDAQ:MMED) with a Buy and raises the price
Gainers bioAffinity Technologies (NASDAQ:BIAF) shares rose 43.1% to $6.53 during Tuesday's regu
On Tuesday, Minimed Group (NASDAQ:MMED) discussed first-quarter financial results during its earning
U.S. stocks were lower, with the Nasdaq Composite falling around 1% on Tuesday. Shares of Yext In
Minimed Group (NASDAQ:MMED) reported quarterly sales of $843.000 million which beat the analyst cons
MiniMed Group, Inc. (MMED) will report Q1 earnings on Sept. 1. Analysts expect 9 cents/share, down f
The FDA authorized Abbott's Libre Duo 10 Day, the first wearable tracking both glucose and keton